Vaccines against gastroenteritis, current progress and challenges.

Area of Science:

• * Infectious Diseases and Vaccinology
• * Microbiology and Immunology

Background:

• * Enteric viral and bacterial infections are major causes of illness and death in young children, the elderly, and immunocompromised individuals globally.
• * Vaccines offer a vital preventive strategy against fecal-to-oral transmitted gastroenteritis, particularly in resource-limited settings lacking adequate sanitation and safe water.
• * Current vaccine availability is limited for many enteric pathogens, despite significant disease burden.

Purpose of the Study:

• * To review the progress and challenges in developing vaccines for key enteric pathogens.
• * To introduce the multiepitope fusion antigen (MEFA) platform for vaccine development.
• * To explore the potential of MEFA in creating broadly protective, multivalent vaccines against heterogeneous enteric pathogens.

Main Methods:

• * Literature review of current enteric vaccine development status.
• * Introduction of the epitope- and structure-based MEFA vaccinology platform.
• * Discussion of MEFA's application for multivalent vaccine design.

Main Results:

• * Significant challenges persist in enteric vaccine development, including strain heterogeneity, lack of animal models, undefined immune correlates, and low efficacy in target populations.
• * The MEFA platform offers a novel approach to address pathogen diversity and develop broadly protective vaccines.
• * MEFA facilitates the design of multivalent vaccines targeting multiple enteric pathogens simultaneously.

Conclusions:

• * Despite challenges, advancements in vaccinology are paving the way for new enteric disease preventives.
• * The MEFA platform represents a promising strategy for developing next-generation vaccines against a wide range of enteric pathogens.
• * Further research and application of MEFA could significantly impact global public health by reducing enteric disease burden.